Journal of Cardiac Failure
Volume 15, Issue 3 , Pages 249-255 , April 2009

A Systematic Review of Studies on Heart Transplantation for Patients With End-Stage Chagas’ Heart Disease

Received 2 June 2008 ,Revised 19 September 2008 ,Accepted 17 October 2008.

References 

  1. Laranja FS, Dias E, Nóbrega G, Miranda A. Chagas’ disease. A clinical, epidemiologic, and pathologic study. Circulation. 1956;14:1035–1060
  2. Bestetti RB, Ramos CP, Figueredo-Silva J, Sales-Neto VN, Oliveira JSM. Ability of the electrocardiogram to detect myocardial lesions in isoproterenol-induced rat cardiomyopathy. Cardiovasc Res. 1987;21:916–921
  3. Rassi- A, Rassi SG, Rassi A. Morte súbita na doença de Chagas. Arq Bras Cardiol. 2001;76:75–85
  4. Bestetti R. Stroke in a hospital-derived cohort of patients with chronic Chagas’ heart disease. Acta Cardiol. 2000;55:33–38
  5. Bestetti RB, Santos CRF, Machado OB, et al. Clinical profile of patients with Chagas' disease before and during ventricular tachycardia. Int J Cardiol. 1990;29:39–46
  6. Rassi- A, Rassi AG, Rassi SG, Rassi- L, Rassi A. Arritmias ventriculares na doença de Chagas. Particularidades diagnósticas, prognósticas e terapêuticas. Arq Bras Cardiol. 1995;65:377–387
  7. Bestetti RB, Ariolli MT, Carmo JL, et al. Clinical characteristics of acute myocardial infarction in patients with Chagas' Disease. Int J Cardiol. 1992;35:371–376
  8. Bestetti RB, Muccillo G. Clinical course of Chagas’ heart disease: a comparison with dilated cardiomyopathy. Int J Cardiol. 1997;60:187–193
  9. Bestetti RB, Dalbo CMR, Arruda CA, Correia-Filho D. Predictors of sudden cardiac death for patients with Chagas’ disease: a hospital-derived cohort study. Cardiology. 1996;87:481–487
  10. Bocchi EA, Bellotti G, Mocelin AO, et al. Heart transplantation for chronic Chagas’ heart disease. Ann Thorac Surg. 1996;61:1727–1733
  11. Bocchi EA, Fiorelli A. The Brazilian experience with heart transplantation: a multicenter report. J Heart Lung Transplant. 2001;20:637–645
  12. Parra AV, Rodrigues VC, Cancella S, Cordeiro JA, Bestetti RB. Impact of socioeconomic status on outcome of a Brazilian heart transplant recipient cohort. Int J Cardiol. 2008;125:142–143
  13. Blanche C, Aleksic I, Takkenberg JM, Czer LSC, Fishbein MC, Trento A. Heart transplantation for Chagas’ cardiomyopathy. Ann Thorac Surg. 1995;60:1406–1409
  14. Freitas HF, Chizzola PR, Paes AT, Lima AC, Mansur AJ. Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' heart disease. Int J Cardiol. 2005;102:239–247
  15. Theodoropoulos TAD, Bestetti RB, Otaviano AP, Cordeiro JA, Rodrigues VC, Silva AC. Predictors of all-cause mortality in chronic Chagas’ heart disease in the current era of heart failure therapy. Int J Cardiol. 2008;128:22–29
  16. Mady C, Cardoso RH, Barreto ACP, da Luz PL, Bellotti G, Pileggi F. Survival and predictors of survival in patients with congestive heart failure due to Chagas’ cardiomyopathy. Circulation. 1994;90:3098–3102
  17. Leirner AA, Moreira LFP, Stolf NAG. The role of circulatory assistance and heart transplantation in Chagas’ disease cardiomyopathy. Art Organs. 2007;31:245–248
  18. Dib JA, Bestetti RB, Freitas PF, Theodoropoulos TA, Cardinalli-Neto A, Cordeiro JA. Predictors of all-cause mortality for patients with Chagas’ cardiomyopathy listed for heart transplantation. Int J Cardiol 2008 Jul 21. [Epub ahead of print]
  19. Cardinalli-Neto A, Bestetti RB, Cordeiro JA, Rodrigues VC. Predictors of all-cause mortality for patients with chronic Chagas’ heart disease receiving implantable cardioverter-defibrillator therapy. J Cardiovasc Electrophysiol. 2007;18:1236–1240
  20. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660–2667
  21. Mehra NR, Kobashigawa Starling R, et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates—2006. J Heart Lung Transplant. 2006;25:1024–1042
  22. Moreira MCV, Magalhães HM, Bordignon S, et al. III. Indicação de transplante cardíaco/seleção. Arq Bras Cardiol. 1999;73(Suppl V):11–20
  23. Carvalho VB, Souza EFL, Vila JHA, et al. Heart transplantation in Chagas’ disease. Circulation. 1996;94:1815–1817
  24. Fiorelli AI, Stolf NA, Honorato R, et al. Later evolution after cardiac transplantation in Chagas’ disease. Transplant Proc. 2005;37:2793–2798
  25. Bacal F, Silva CP, Bocchi EA, et al. Mycophenolate Mofetil increased Chagas’ disease reactivation in heart transplanted patients: comparison between two different protocols. Am J Transplant. 2005;5:2017–2021
  26. Bestetti RB, Souza TR, Lima MF, Theodoropoulos TAD, Cordeiro JA, Burdmann EA. Effects of a mycophenolate mofetil-based immunosuppressive regimen in Chagas’ heart transplant recipients. Transplantation. 2007;84:441–442
  27. Bestetti RB, Theodoropoulos TAD, Burdmann EA, Abbud-Filho M, Cordeiro JA, Villafanha D. Switch from calcineurin inhibitors to sirolimus-induced renal recovery in heart transplant recipients in the midterm follow-up. Transplantation. 2006;81692–81696
  28. Souza MM, Franco M, Almeida DR, et al. Comparative histopathology of endomyocardial biopsies in chagasic and non-chagasic heart transplant recipients. J Heart Lung Transplant. 2000;220:534–543
  29. Taylor DO, Edwards LB, Boucek MA, et al. The registry of the International Society for Heart and Lung Transplantation: 22nd official adult heart transplant report-2005. J Heart Lung Transplant. 2005;24:804
  30. Cupoletti A, Perez-Villa F, Vallejos I, Roig E. Experience with single-dose daclizumab in the prevention of acute rejection in heart transplantation. Transplant Proc. 2005;37:4036–4038
  31. Kobashigawa J, Miller L, Dale R, et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Transplantation. 1998;66:507–515
  32. Bocchi EA, Bellotti G, Uip D, et al. Long-term follow up after heart transplantation in Chagas’ disease. Transplant Proc. 1993;25:1329–1330
  33. Kobashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med. 1995;333:621–627
  34. Kobashigawa J, Meiser BM. Review of major clinical trials with Mycophenolate Mofetil in cardiac transplantation. Transplantation. 2005;80(Suppl 2S):S235–S243
  35. Sartori AMC, Ibrahim KY, Westphalen EVN, et al. Manifestations of Chagas’ disease (American Trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol. 2007;101:31–50
  36. Sartori AMC, Eluf-Neto J, Nunes EV, et al. Trypanosoma cruzi parasitemia in chronic Chagas’ disease: comparison between human immunodeficiency virus (HIV)-positive and HIV negative patients. J Infect Dis. 2002;186:872–875
  37. Stolf NAG, Higushi L, Bocchi E, et al. Heart transplantation in patients with Chagas’ disease cardiomyopathy. J Heart lung Transplant. 1987;6:307–312
  38. Couto WJ, Branco JNR, Almeida D, et al. Transplante cardíaco e infecção. Rev Bras Cir Cardiovasc. 2001;16:141–151
  39. Bestetti RB, Cury PM, Theodoropoulos TAD, Villafanha D. Trypanosoma cruzi infection reactivation presenting as complete atrioventricular block in a Chagas’ heart transplant recipient. Cardiovasc Pathol. 2004;13:323–326
  40. Teixeira VAP, Araújo MBM, Reis MA, et al. Possible role of an adrenal parasite reservoir in the pathogenesis of Trypanosoma cruzi myocarditis. Trans Roy Soc Trop Méd Hyg. 1993;87:552–554
  41. Schijman AG, Vigliano C, Burgos J, et al. Early diagnosis of recurrence of Trypanosoma cruzi infection by polymerase chain reaction after heart transplantation of a chronic Chagas’ heart disease patient. J Heart Lung Transplant. 2000;19:114–117
  42. Rottenberg ME, Cardoni RL, Sinagra A, et al. Trypanosoma cruzi: T-cell-dependent mechanisms of resistance during chronic infection. Exp Parasitol. 1991;73:127–136
  43. Boullon F, Sinagra A, Riarte A, et al. Experimental cardiac transplantation in chronic Chagas’ disease in dogs. Transplant Proc. 1988;20:432–437
  44. Bestetti RB, Castilho OT, Teno LAC, Freitas OC. Absence of Trypanosoma cruzi myocardial infection reactivation in Chagas’ heart transplant. Cardiovasc Pathol. 1994;3:257–259
  45. Campos SV, Strabelli TMV, Amato-Neto V, et al. Risk factors for Chagas’ disease reactivation after heart transplantation. J Heart Lung Transplant. 2008;27:597–602
  46. Almeida DR, Carvalho AC, Branco JN, et al. Chagas’ disease reactivation after heart transplantation: efficacy of allopurinol treatment. J Heart Transplant. 1996;15:988–992
  47. Bocchi EA, Fiorelli A. The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. Ann Thorac Surg. 2001;71:1833–1838
  48. Diez M, Favaloro L, Bertolloti A, et al. Usefulness of PCR strategies for early diagnosis of Chagas’ disease reactivation and treatment follow up in heart transplantation. Am J Transplant 207;7:1633–1640.

 No conflicts of interest and no sources of funding disclosed.

PII: S1071-9164(08)01047-6

doi: 10.1016/j.cardfail.2008.10.023

Journal of Cardiac Failure
Volume 15, Issue 3 , Pages 249-255 , April 2009

Article Tools